Review article · 2016 · Open access

A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics

Aschalew Alemu Marie, Hailemeskel Mekonnen, Shewatateke Gedamu

Advances in life science and technology, 42(2), 42–50 · Published 1 January 2016

Open PDFView at the publisherCite this paper

In brief

“A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics” is a 2016 review article by Aschalew Alemu Marie and 2 co-authors, published in Advances in life science and technology. OpenAlex counts 0 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Journals & Books Hosting (International Knowledge Sharing Platform).

Citations
0
References
30
Authors
3

Abstract

Over the past decade, second-generation antipsychotic medications have become the first-line treatment for schizophrenia. But efficacy of second generation antipsychotic compared with first generation antipsychotic in patients with schizophrenia has not been sufficiently addressed. The study objective was to perform a meta-analysis of randomized trials compare the efficacy of second generation antipsychotic (SGAs) vs. first generation antipsychotics (FGAs). Searches were conducted for randomized, blinded studies comparing one or more of nine second- generation antipsychotics in the treatment of schizophrenia with first generation antipsychotic which published from 2003 till 2013 from nature, Pubmed central, and henari website. The primary outcome measure was change in total score on the Positive and Negative Syndrome Scale; secondary outcome measures were positive and negative symptom subs cores. The results were combined in comprehensive meta- analysis version 2 software. The analysis included 9 studies, the meta-analysis comparing FGAs and SGAs using change in total PANSS, score, the odds ratio is 1.407 with 95 % confidence interval of 1.016-1.948 z- value of 2.055 and p-value 0.04(p<0.05) indicating the result of analysis is statistically significant. The odds ratio is falls above 1 indicating the patient treated with second generation antipsychotic were more likely reduce total PANSS score than first generation antipsychotic. In conclusion, Second generation antipsychotic is superior in reducing total PANSS score than first generation antipsychotic. Regard to resperidone and olanzapine, they are homogenous in reducing total PANSS score. Keywords: Efficacy, antipsychotic, second generation antipsychotic, first generation antipsychotic, PANSS score, meta-analysis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Marie, A. A., Mekonnen, H., & Gedamu, S. (2016). A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics. Advances in life science and technology, 42(2), 42–50. https://www.iiste.org/Journals/index.php/ALST/article/download/29324/30113

MLA 9

Marie, Aschalew Alemu, et al. “A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics.” Advances in life science and technology, vol. 42, no. 2, 2016, pp. 42–50. https://www.iiste.org/Journals/index.php/ALST/article/download/29324/30113.

Chicago

Marie, Aschalew Alemu, Hailemeskel Mekonnen, and Shewatateke Gedamu. 2016. “A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics.” Advances in life science and technology 42 (2): 42–50. https://www.iiste.org/Journals/index.php/ALST/article/download/29324/30113.

Harvard

Marie, A. A., Mekonnen, H. and Gedamu, S. (2016) ‘A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics’, Advances in life science and technology, 42(2), pp. 42–50. Available at: https://www.iiste.org/Journals/index.php/ALST/article/download/29324/30113.

IEEE

A. A. Marie, H. Mekonnen, and S. Gedamu, “A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics,” Advances in life science and technology, vol. 42, no. 2, pp. 42–50, 2016.

BibTeX

@article{marie2016meta,
  title     = {{A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics}},
  author    = {Marie, Aschalew Alemu and Mekonnen, Hailemeskel and Gedamu, Shewatateke},
  journal   = {Advances in life science and technology},
  year      = {2016},
  volume    = {42},
  number    = {2},
  pages     = {42--50},
  url       = {https://www.iiste.org/Journals/index.php/ALST/article/download/29324/30113}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • atypical antipsychotics
  • typical antipsychotics
  • schizophrenia
  • antipsychotic efficacy
  • PANSS
  • positive and negative symptoms
  • risperidone
  • olanzapine

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Marie, A. A., Mekonnen, H., & Gedamu, S. (2016). A Meta-Analysis of Randomized Control Trial on the Efficacy of Second Generation Antipsychotics. Advances in life science and technology, 42(2), 42–50. https://www.iiste.org/Journals/index.php/ALST/article/download/29324/30113

How many times has this paper been cited?

0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journals & Books Hosting (International Knowledge Sharing Platform): sign in and open the PDF from this page.

Who wrote this paper?

Aschalew Alemu Marie, Hailemeskel Mekonnen, Shewatateke Gedamu.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.